DNA strands in materials act like traffic signals to start, stop cell activity or regenerate tissue
A groundbreaking advancement in materials from Northwestern University could potentially help patients requiring stem cell therapies for spinal cord injuries, stroke, Parkinson’s disease, Alzheimer’s disease, arthritic joints or any other condition requiring tissue regeneration, according to a new study.
“It’s important in the context of cell therapies for people to cure these diseases or regenerate tissues that are no longer functional,” said senior author Samuel I. Stupp, director of Northwestern’s Simpson Querrey Institute for BioNanotechnology and Board of Trustees Professor of Materials Science and Engineering, Chemistry, Medicine and Biomedical Engineering.
Cells in our bodies are constantly being signaled with many types of instructions coming from proteins and other molecules present in the matrices that surround them. For example, these can be cues for cells to express specific genes so they can proliferate or differentiate into several types of cells leading to growth or regeneration of tissues. One of the marvels of this signaling machinery is the built-in capacity in living organisms to make signals stop and re-start as needed, or to switch off one signal and activate a different one to orchestrate very complex processes. Building artificial materials with this type of dynamic capacity for regenerative therapies has been virtually impossible so far.
New technology could be useful in therapies using patient-derived stem cells to regenerate tissue
The new work published today reports the development of the first synthetic material that has the capability to trigger reversibly this type of dynamic signaling. The platform could not only lead to materials that manage stem cells for more effective regenerative therapies, but will also allow scientists to explore and discover in the laboratory new ways to control the fate of cells and their functions.
One of the findings is the possibility of using the synthetic material to signal neural stem cells to proliferate, then at a specific time selected by the operator, trigger their differentiation into neurons and then return the stem cells back to a proliferative state on demand.
The paper also reports that spinal cord neural stem cells, initially grouped into structures known as “neurospheres,” can be driven to spread out and differentiate using a signal. But when this signal is switched off, the cells spontaneously re-group themselves into colonies. This uncovers strong interactions among these cells that could be important in understanding developmental and regenerative cues.
Stem cell proliferation and differentiation can be triggered over multiple cycles with new materials technology
The potential use of the new technology to manipulate cells could help cure a patient with Parkinson’s disease. The patient’s own skin cells could be converted to stem cells using existing techniques. The new technology could help expand the newly converted stem cells in vitro – in the lab – and then drive their differentiation into dopamine-producing neurons before transplantation back to the patient.
In the new technology, materials are chemically decorated with different strands of DNA, each designed to display a different signal to cells. To activate signals to cells, soluble molecules containing complementary DNA strands coupled to peptides are added to the material to create DNA double helices displaying the signal. By adding a few drops of the DNA-peptide conjugate, a green light is given to produce more stem cells. The approach to provide the material with dynamic intelligence is to expose the surface to a soluble single-stranded DNA molecule designed to “grab” the signal-containing strand of the duplex and form a new DNA double helix. This new duplex is no longer attached to the material surface and washes away, thus switching the biological signal off. To turn the signal back on, all that is needed is to now introduce a new copy of single-stranded DNA bearing a signal that will reattach to the material’s surface.
“People would love to have cell therapies that utilize stem cells derived from their own bodies to regenerate tissue,” Stupp said. “In principle, this will eventually be possible, but one needs procedures that are effective at expanding and differentiating cells in order to do so. Our technology does that.”
Starting or stopping cell activity existed before; this research discovered how to re-start and stop again cell activity several times
While this process is currently only done in vitro with the vision of then transplanting cells, Stupp said in the future it might be possible to perform this process in vivo. The stem cells would be implanted in the clinic, encapsulated in the type of material described in the new work, via an injection and targeted to a particular spot. Then the soluble molecules would be given to the patient to manipulate proliferation and differentiation of transplanted cells.
The Latest on: Tissue regeneration
- Humans' 'inner salamander' capacity could regrow cartilageon October 18, 2019 at 10:09 am
These microRNAs are also found in humans—an evolutionary artifact that provides the capability in humans for joint tissue repair, according to a press release by Duke Health. "We were excited to learn ...
- Case report: Repair of osseous defect on an implanton October 18, 2019 at 12:04 am
Treatment consisted of debridement and disinfection with the Solea dental laser (Convergent Dental), a 9.3-µm CO 2 laser, with guided bone regeneration. The clinical objectives were to remove the ...
- Tissue Engineering Market Increasing the Growth Worldwide and Forecast 2026on October 17, 2019 at 4:55 am
Tissue engineering is basically used to restore or construct injured body parts or tissue. Moreover, it is also used in the regeneration of damaged tissues by combining cells from the body with highly ...
- Aroa Biosurgery Appoints New Vice President, Commercialon October 16, 2019 at 5:12 pm
Aroa Biosurgery, a New Zealand-headquartered, emerging global leader for tissue regeneration products used in complex wounds and soft tissue repair, has announced the appointment of a highly ...
- Engineering biomimetic microvascular meshes for subcutaneous islet transplantationon October 16, 2019 at 6:33 am
To successfully engineer cell or tissue implants, bioengineers must facilitate their metabolic requirements through vascular regeneration. However, it is challenging to develop a broad strategy for ...
- RegeneRx JV Partner Updates on Strategic Dry Eye Discussionson October 16, 2019 at 5:17 am
ROCKVILLE, Md., Oct. 16, 2019 /PRNewswire/ --RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, ...
- Astronauts 3D print space meaton October 16, 2019 at 4:00 am
Led by cosmonaut Oleg Skripochka, the team conducted the artificial meat experiments by replicating the muscle-tissue regeneration process that naturally occurs within cows. The team produced a small ...
- Nerve Regeneration and Repair Market 2019 Application and Future Forecast by 2024 - Market Research Engineon October 14, 2019 at 12:20 pm
Oct 14, 2019 (Heraldkeepers) -- New York, October 14, 2019: Frequency of neurological injury is high, nerve regeneration and repair, a sub field of neural tissue building, is turning into a quickly ...
- U of T researcher develops nanosystem that promotes regeneration after root canalson October 11, 2019 at 9:21 am
Anil Kishen has developed an organically based nanosystem to promote tissue regeneration inside teeth after root canal treatments (photo by Jeff Comber) A novel nanosystem developed by Anil Kishen, a ...
- Sustained elevation of MG53 in the bloodstream increases tissue regenerative capacity without compromising metabolic functionon October 11, 2019 at 2:17 am
MG53 is a muscle-specific TRIM-family protein that presides over the cell membrane repair response. Here, we show that MG53 present in blood circulation acts as a myokine to facilitate tissue ...
via Google News and Bing News